IIL logo

Intravenous Infusions Plc Stock Price

GHSE:IIL Community·GH₵181.1m Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 15 Fair Values set on narratives written by author

IIL Share Price Performance

GH₵0.72
0.67 (1,340.00%)
GH₵0.72
0.67 (1,340.00%)
Price GH₵0.72

IIL Community Narratives

There are no narratives available yet.

Trending Discussion

No trending discussion available.

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Moderate risk with worrying balance sheet.

5 Risks
0 Rewards

Intravenous Infusions Plc Key Details

GH₵9.3m

Revenue

GH₵8.0m

Cost of Revenue

GH₵1.3m

Gross Profit

GH₵5.9m

Other Expenses

-GH₵4.6m

Earnings

Last Reported Earnings
Dec 31, 2025
Next Reporting Earnings
n/a
-0.017
14.07%
-49.78%
86.2%
View Full Analysis

About IIL

Founded
1969
Employees
n/a
CEO
Moukhtar Soalihu
WebsiteView website
www.iil.com.gh

Intravenous Infusions Plc, a pharmaceutical company, engages in the manufacturing and marketing of intravenous infusions and small volume injectables for therapeutic purposes in Ghana and the West African sub-region. It provides pethidine, such as chloroquine phosphate and quinine dihydrochloride injections. The company was incorporated in 1969 and is based in Koforidua, Ghana.

Recent IIL News & Updates

Recent updates

No updates

Intravenous Infusions Plc Competitors